4.6 Article

Global accessibility of therapeutics for diabetes mellitus

Journal

NATURE REVIEWS ENDOCRINOLOGY
Volume 18, Issue 4, Pages 199-204

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41574-021-00621-y

Keywords

-

Funding

  1. National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM)
  2. NIHR Leicester Biomedical Research Centre (BRC)

Ask authors/readers for more resources

This paper discusses the differences and barriers in diabetes treatment and proposes potential solutions.
Diabetes mellitus is a global health issue, yet huge regional disparities exist in its care, including in access to basic necessities such as insulin. In this Viewpoint, six experts from different regions discuss differences in access to insulin and other diabetes mellitus therapies as well as the key barriers in diabetes mellitus care accessibility and potential solutions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available